Drug properties & optimzation II 03 (1/3)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/14

encourage image

There's no tags or description

Looks like no tags are added yet.

15 Terms

1
New cards

Stomach environment

- Strongly acidic (pH 1-3) enviro where little absorption occurs

- D must:

1. Be sufficiently water-soluble to dissolve in GI fluids

2. Have sufficient stability in stomach acid

<p>- Strongly acidic (pH 1-3) enviro where little absorption occurs </p><p>- D must:</p><p>1. Be sufficiently water-soluble to dissolve in GI fluids</p><p>2. Have sufficient stability in stomach acid</p>
2
New cards

Intestinal environment

  • Mildly acidic to near-neutral pH (~5.5–7.5)

  • Bile salts form micelles that aid fat digestion & solubilize lipophilic D’s

  • SI has a large SA, most oral D absorption occurs in SI


<ul><li><p>Mildly acidic to near-neutral pH (~5.5–7.5) </p></li><li><p>Bile salts form micelles that aid fat digestion &amp; solubilize lipophilic D’s </p></li><li><p>SI has a large SA, most oral D absorption occurs in SI </p></li></ul><p></p>
3
New cards

Drug absorption by passive diffusion (journey)


<p></p>
4
New cards

Liver & first-pass metabolism

- After intestinal absorption, D's enter portal circulation → carried to liver

- Liver enzymes metabolize D's & other compounds

- D metabolism includes Phase I and II

- First-pass metabolism ↓ amount of D reaching bloodstream

<p>- After intestinal absorption, D's enter portal circulation → carried to liver </p><p>- Liver enzymes metabolize D's & other compounds </p><p>- D metabolism includes Phase I and II </p><p>- First-pass metabolism ↓ amount of D reaching bloodstream</p>
5
New cards

Drug metabolism phases (liver & first-pass)

1. Phase I: oxidation, reduction or hydrolysis

2. Phase II: conjugation

<p>1. Phase I: oxidation, reduction or hydrolysis </p><p>2. Phase II: conjugation</p>
6
New cards

Drug transport in blood

- Blood plasma is mostly water

- Lipophilic D's bind to plasmaproteins

- D's circulate in 2 forms: unbound or protein-bound

- Blood contains enzymes that can break down certain D's: esterases and proteases

<p>- Blood plasma is mostly water</p><p>- Lipophilic D's bind to plasmaproteins</p><p>- D's circulate in 2 forms: unbound or protein-bound</p><p>- Blood contains enzymes that can break down certain D's: esterases and proteases</p>
7
New cards

Kidney clearance of drugs

- Kidneys remove D's & metabolites from blood via urine

↳ Hydrophilic D's r more readily eliminated in urine

↳ Lipophilic D's may be reabsorbed into bloodstream

- Metabolism can convert lipophilic D's into more water-soluble compounds = easier elimination

<p>- Kidneys remove D's & metabolites from blood via urine </p><p>↳ Hydrophilic D's r more readily eliminated in urine </p><p>↳ Lipophilic D's may be reabsorbed into bloodstream </p><p>- Metabolism can convert lipophilic D's into more water-soluble compounds = easier elimination</p>
8
New cards

Drug distribution to target organs

- D's must reach their target tissues or organs to prod an effect

- Many small-molecule D's enter tissues by passive diffusion

- Sufficient D must reach T to prod a therapeutic response

9
New cards

Barriers to drug delivery (oral dosing)

- D properties must be optimized to ensure sufficient D reaches its T

- Oral D's encounter many barriers: solubility, stability, permeability, metabolism

- These processes are described by ADME:

↳ Absorption; Distribution; Metabolism; Excretion

<p>- D properties must be optimized to ensure sufficient D reaches its T</p><p>- Oral D's encounter many barriers: solubility, stability, permeability, metabolism</p><p>- These processes are described by ADME:</p><p>↳ Absorption; Distribution; Metabolism; Excretion</p>
10
New cards

Lipinski's rule of five

- Rapid assessment of drug-like physicochem properties

- Identifies compounds at risk of poor oral absorption or permeability

- Based on patterns observed in known D's

- Guideline, not guarantee of oral bioavailability

- Predictions must be confirmed experimentally

11
New cards

Lipinski Rule of 5 checklist

2 or more violated = more likely to have poor oral absorption:

1. Over 5 H-bond donors

2. Over 10 H-bond acceptors

3. Molecular weight >500 Da

4. Calculated LogP > 5 (or measured LogP > ~4.15 in the og formulation)

<p>2 or more violated = more likely to have poor oral absorption:</p><p>1. Over 5 H-bond donors</p><p>2. Over 10 H-bond acceptors</p><p>3. Molecular weight &gt;500 Da</p><p>4. Calculated LogP &gt; 5 (or measured LogP &gt; ~4.15 in the og formulation)</p>
12
New cards

Hydrogen bonding: rationale for Rule of 5

- H-bonds ↑ water solubility, too many make it difficult to cross lipophilic memb

- Balance btwn aq solubility & memb permeability is important

<p>- H-bonds ↑ water solubility, too many make it difficult to cross lipophilic memb</p><p>- Balance btwn aq solubility &amp; memb permeability is important</p>
13
New cards

Hydrogen-bond donors (HBD)

- Typically, OH and NH groups (H-EN atom)

- Count donor groups, not individual H atoms

- Ex: -NH₂ = 1 HBD

<p>- Typically, OH and NH groups (H-EN atom)</p><p>- Count donor groups, not individual H atoms </p><p>- Ex: -NH₂ = 1 HBD</p>
14
New cards

Hydrogen-bond acceptors (HBA)

- Atoms w suitable available LP's, commonly O or N

- Not every N or O is an acceptor

- Ex: amide nitrogen = 0 HBA (unavailable, involved in resonance)

<p>- Atoms w suitable available LP's, commonly O or N </p><p>- Not every N or O is an acceptor</p><p>- Ex: amide nitrogen = 0 HBA (unavailable, involved in resonance)</p>
15
New cards

Molecular weight: rationale for Rule of 5

- Larger molecules struggle crossing biolo memb's by passive diffusion

- ↑ing molecular size can also complicate aq solubility & D formulation

- MW > 500 Da is a useful warning threshold for oral druglikeness, not an absolute limit

<p>- Larger molecules struggle crossing biolo memb's by passive diffusion</p><p>- ↑ing molecular size can also complicate aq solubility &amp; D formulation</p><p>- MW &gt; 500 Da is a useful warning threshold for oral druglikeness, not an absolute limit</p>